-
CORPORATE
- DOJIN GROUP
Notice Regarding the Establishment of a Chinese Subsidiary
-
PRODUCTS
- DICI (Dojin Institute of Cancer Immunology)
Announcement of New Product Release: regenerative factor injection therapy “R...
-
OTHER
- DOJIN GROUP
Regarding Changes in Business Hours to Respond to the Spread of COVID-19
-
OTHER
- DOJIN GROUP
Regarding Changes in Business Hours to Respond to the Spread of COVID-19
-
CORPORATE
- DOJIN GROUP
Announcement of Acquisition of Shares of Beacle Co., Ltd.
-
CORPORATE
- DOJIN GROUP
Notice Regarding Acquisition of Shares of Cell Technology Co., Ltd.
-
CORPORATE
- DICI (Dojin Institute of Cancer Immunology)
Notice of Initiation of Joint Research with National Cancer Center
-
CORPORATE
- DICI (Dojin Institute of Cancer Immunology)
Announcement of AMED adoption in joint research with the National Cancer Cent...
-
PRODUCTS
- DOJIN PHARMA
Announcement of Product Release – Diagnostic Supplement Service “PICK” –
-
OTHER
- DOJIN GROUP
Regarding Changes in Business Hours to Respond to the Spread of COVID-19